My Background

Dr. Peter-Brian Andersson, MD, PhD, is a board-certified neurologist with extensive training from Oxford, Stanford, and UCLA, offering expert, patient-focused care in brain, nerve, and muscle disorders.He combines decades of clinical experience with a deep commitment to advancing neurological wellness. Dr. Andersson is dedicated to accurate diagnosis, compassionate care, and long-term patient partnerships.

Dr. Peter-Brian Andersson, MD, PhD – Professional Background

Education & Academic Honors

  • MBChB, University of Cape Town (cum laude, 1981–1986)

  • BSc (Med) (Hons) in Medical Biochemistry, University of Cape Town (1988)

  • DPhil in Neuroimmunology, University of Oxford (1988–1991)

  • Rhodes Scholar, University of Oxford (1988–1991)

  • Alpha Omega Alpha Honor Society, 1997–Present

Academic & Research Appointments

  • College Lecturer in Immunology, Christ Church, Oxford (1989–1992)

  • Yamanouchi Junior Research Fellow in Cell Biology, Wolfson College, Oxford (1991–1992)

  • Clinical Assistant Professor of Neurology, UCLA (2002–2007)

  • Clinical Associate Professor of Neurology, UCLA (2008–2022)

Academic & Research Appointments

  • Resident and Chief Resident, University of California, San Francisco (1993–1996)

  • Fellow in Neuroimmunology & Multiple Sclerosis, UCSF (1996–1997)

  • Fellow in Neuromuscular Disease, Stanford University (1998–1999)

  • Southern California SuperDoctors®, 2010–2023

Leadership & Professional Roles

  • Stroke Program Co-Director, Providence Tarzana Hospital (2011–2015)

  • Founder & CEO, Neurology Consulting, Inc. (2017–Present)

  • Medical Director for California, Stratus Neurodiagnostics (2018–Present)

  • Medical Director, California Neurodiagnostics (2018–Present)

places in different places
different places in provoked
different places in hospital
Hospitals in different places
department of hospital
Area of hospital
CERTIFICATION AANEM
CERTIFICATION

CERTIFICATION

Board Certified in Neurology, American Board of Psychiatry & Neurology, 1998 Board Certified in Clinical Neurophysiology, American Board of Electrodiagnostic Medicine 2000 Board Certified in Clinical Neurophysiology, American Board of Psychiatry and Neurology 2001
RESEARCH

RESEARCH

Co-Investigator examining physician IDEAS Study 2016-2017 Co-investigator examining physician National Research Institute XanADu Trial 2017-2019 Co-Investigator National Research Institute Lilly LDMC Study 2019-2020 Co-investigator National Research Institute XanamemTM for Alzheimers Disease 2018-9 Principal Investigator National Research Institute T3D-959 Study 2019-2022